OBJECTIVE: To determine the comparable safety and efficacy of cutting balloon angioplasty ( @entity11643 ) and balloon angioplasty (BA) for @entity256 (ISR). BACKGROUND: Previous studies have found that diffuse-type ISR predicts recurrence of ISR. The efficacy of @entity11643 in this clinical setting is incompletely documented. METHODS AND RESULTS: One-hundred and seven consecutive @entity66 (length > 10 mm) in 104 @entity1 treated by @entity11643 or BA were retrospectively analyzed. @entity11643 was used in 61 lesions and BA in 46 lesions. Initial success (residual restenosis 30% with no major complications) was achieved in 99% of cases in each group. Follow-up angiography was performed in all @entity1 at 131 93 days. Although the percent diameter stenosis after @entity11643 was lower than after BA (19 12% versus 27 12%; p = 0.001), intravascular ultrasound (IVUS) or other QCA data were similar in the 2 groups. In follow-up angiography, recurrent restenosis rate was not statistically different between @entity11643 (34%) and BA (52%); however, recurrent diffuse ISR was lower in the @entity11643 group (20%) than the BA group (48%; p = 0.01). Lesion length at follow-up in the @entity11643 group was smaller compared to the BA group (15.9 7.3 mm versus 24.2 14.4 mm; p < 0.05), while lesion length before procedure was similar. CONCLUSION: @entity11643 for ISR is safe and effective with favorable long-term outcomes. This effect is mainly due to shortening lesion length.

The impact of cutting balloon angioplasty for the treatment of XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity11643 :: ('CHEBI:3796', 'Chemical') :: ['CBA'] @entity256 :: ('MESH:D023903', 'Disease') :: ['diffuse in-stent restenosis'] @entity66 :: ('MESH:D004194', 'Disease') :: ['diffuse ISR lesions']
@entity256 :: (MESH:D023903,Disease) :: ['diffuse in-stent restenosis']
